A settlement over alleged improper marketing of Zyprexa has been expected since October, when Eli Lilly said it set aside $1.42 billion for a settlement, reports say.
More: continued here
A settlement over alleged improper marketing of Zyprexa has been expected since October, when Eli Lilly said it set aside $1.42 billion for a settlement, reports say.
More: continued here